Gainers
- Intensity Therapeutics INTS stock increased by 107.2% to $8.29 during Friday's regular session. The company's market cap stands at $113.6 million.
- Conduit Pharmaceuticals CDT stock moved upwards by 37.53% to $4.87. The company's market cap stands at $359.4 million.
- ALX Oncology Holdings ALXO stock moved upwards by 34.59% to $12.45. The company's market cap stands at $620.2 million.
- Exicure XCUR shares rose 32.09% to $0.53. The market value of their outstanding shares is at $4.5 million.
- Rani Therapeutics Hldgs RANI stock rose 27.39% to $3.33. The company's market cap stands at $86.0 million.
- Allarity Therapeutics ALLR shares increased by 22.93% to $0.6. The market value of their outstanding shares is at $2.8 million.
Losers
- AquaBounty Techs AQB stock fell 19.6% to $3.04 during Friday's regular session. The market value of their outstanding shares is at $11.6 million.
- Veradigm MDRX shares declined by 18.99% to $10.2. The company's market cap stands at $1.1 billion.
- Cano Health CANO shares decreased by 16.37% to $9.03. The market value of their outstanding shares is at $26.0 million.
- Kazia Therapeutics KZIA shares fell 16.03% to $0.36. The market value of their outstanding shares is at $9.5 million.
- Sera Prognostics SERA stock decreased by 15.45% to $4.27. The market value of their outstanding shares is at $133.8 million.
- Kintara Therapeutics KTRA stock decreased by 15.4% to $0.22. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ALXOALX Oncology Holdings Inc
$1.83-2.04%
AQBAquaBounty Technologies Inc
$0.724224.6%
CDTConduit Pharmaceuticals Inc
$0.05724.95%
INTSIntensity Therapeutics Inc
$1.91-2.42%
KZIAKazia Therapeutics Ltd
$2.97-%
MDRXVeradigm Inc
--%
RANIRani Therapeutics Holdings Inc
$1.441.41%
SERASera Prognostics Inc
$8.36-2.79%
XCURExicure Inc
$17.04-12.8%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in